[English] 日本語
Yorodumi
- PDB-7msg: The crystal structure of LIGHT in complex with HVEM and CD160 -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 7msg
TitleThe crystal structure of LIGHT in complex with HVEM and CD160
Components
  • CD160 antigen, soluble form,Tumor necrosis factor receptor superfamily member 14
  • Tumor necrosis factor ligand superfamily member 14, membrane form
KeywordsIMMUNE SYSTEM / IMMUNITY / N-GLYCOSYLATION / MEMBRANE / SECRETED PROTEIN / CYTOKINE / JELLY-ROLL FOLD / CYSTEINE RICH DOMAIN / SIGNALING / CELL MEMBRANE / SECRETED / IMMUNOGLOBULIN SUPERFAMILY / TNF
Function / homology
Function and homology information


positive regulation of natural killer cell mediated immune response to tumor cell / activating MHC class I receptor activity / negative regulation of CD4-positive, alpha-beta T cell costimulation / negative regulation of adaptive immune memory response / positive regulation of natural killer cell degranulation / negative regulation of alpha-beta T cell proliferation / MHC class I protein complex binding / MHC class Ib receptor activity / positive regulation of natural killer cell cytokine production / mucosal immune response ...positive regulation of natural killer cell mediated immune response to tumor cell / activating MHC class I receptor activity / negative regulation of CD4-positive, alpha-beta T cell costimulation / negative regulation of adaptive immune memory response / positive regulation of natural killer cell degranulation / negative regulation of alpha-beta T cell proliferation / MHC class I protein complex binding / MHC class Ib receptor activity / positive regulation of natural killer cell cytokine production / mucosal immune response / tumor necrosis factor receptor activity / MHC class I receptor activity / TNFs bind their physiological receptors / TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway / positive regulation of T cell chemotaxis / positive regulation of cytokine production involved in immune response / positive regulation of natural killer cell mediated cytotoxicity / Co-inhibition by BTLA / T cell chemotaxis / cysteine-type endopeptidase inhibitor activity involved in apoptotic process / tumor necrosis factor receptor binding / positive regulation of extrinsic apoptotic signaling pathway / positive regulation of myoblast fusion / negative regulation of T cell receptor signaling pathway / cytokine binding / T cell homeostasis / positive regulation of endothelial cell apoptotic process / positive regulation of myoblast differentiation / positive regulation of T cell migration / T cell proliferation / side of membrane / negative regulation of T cell proliferation / T cell costimulation / T cell activation / negative regulation of angiogenesis / cytokine activity / TNFR2 non-canonical NF-kB pathway / phosphatidylinositol 3-kinase/protein kinase B signal transduction / cellular response to mechanical stimulus / positive regulation of non-canonical NF-kappaB signal transduction / kinase binding / positive regulation of type II interferon production / Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell / virus receptor activity / angiogenesis / defense response to Gram-negative bacterium / adaptive immune response / cell surface receptor signaling pathway / positive regulation of canonical NF-kappaB signal transduction / defense response to Gram-positive bacterium / immune response / receptor ligand activity / signaling receptor binding / innate immune response / external side of plasma membrane / apoptotic process / ubiquitin protein ligase binding / signal transduction / extracellular space / extracellular region / identical protein binding / plasma membrane / cytoplasm
Similarity search - Function
CD160 ANTIGEN / Tumour necrosis factor receptor 14 / Tumor necrosis factor receptor 14/UL144, N-terminal / Tumour necrosis factor / Tumor Necrosis Factor Receptor, subunit A, domain 2 / Tumor Necrosis Factor Receptor, subunit A; domain 2 / Tumour necrosis factor family. / TNFR/NGFR family cysteine-rich region domain profile. / TNFR/NGFR cysteine-rich region / TNF(Tumour Necrosis Factor) family ...CD160 ANTIGEN / Tumour necrosis factor receptor 14 / Tumor necrosis factor receptor 14/UL144, N-terminal / Tumour necrosis factor / Tumor Necrosis Factor Receptor, subunit A, domain 2 / Tumor Necrosis Factor Receptor, subunit A; domain 2 / Tumour necrosis factor family. / TNFR/NGFR family cysteine-rich region domain profile. / TNFR/NGFR cysteine-rich region / TNF(Tumour Necrosis Factor) family / TNFR/NGFR family cysteine-rich region signature. / Tumor necrosis factor receptor / nerve growth factor receptor repeats. / TNFR/NGFR cysteine-rich region / Tumour necrosis factor domain / Tumor necrosis factor (TNF) homology domain (THD) profile. / Tumour necrosis factor-like domain superfamily / Ribbon / Immunoglobulin-like domain superfamily / Immunoglobulin-like fold / Mainly Beta
Similarity search - Domain/homology
Tumor necrosis factor ligand superfamily member 14 / CD160 antigen / Tumor necrosis factor receptor superfamily member 14
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.5 Å
AuthorsLiu, W. / Ramagopal, U. / Garrett-Thompson, S.C. / Fedorov, E. / Bonanno, J.B. / Almo, S.C.
Funding support United States, 11items
OrganizationGrant numberCountry
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)P41GM103473 United States
Department of Energy (DOE, United States)DE-AC02-98CH10886 United States
National Institutes of Health/National Center for Research Resources (NIH/NCRR)P41RR012408 United States
Department of Energy (DOE, United States)DE-AC02-06CH11357 United States
National Institutes of Health/National Cancer Institute (NIH/NCI)P30CA013330 United States
National Institutes of Health/Office of the DirectorS10OD020068 United States
National Institutes of Health/National Cancer Institute (NIH/NCI)P30CA023100 United States
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK)P30DK120515 United States
National Institutes of Health/National Center for Research Resources (NIH/NCRR)S10RR027366 United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)U01AI125955 United States
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK)P01DK46763 United States
CitationJournal: J.Exp.Med. / Year: 2021
Title: HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
Authors: Liu, W. / Chou, T.F. / Garrett-Thomson, S.C. / Seo, G.Y. / Fedorov, E. / Ramagopal, U.A. / Bonanno, J.B. / Wang, Q. / Kim, K. / Garforth, S.J. / Kakugawa, K. / Cheroutre, H. / Kronenberg, M. / Almo, S.C.
History
DepositionMay 11, 2021Deposition site: RCSB / Processing site: RCSB
Revision 1.0Oct 27, 2021Provider: repository / Type: Initial release
Revision 1.1Nov 10, 2021Group: Database references / Category: citation / citation_author
Item: _citation.country / _citation.journal_abbrev ..._citation.country / _citation.journal_abbrev / _citation.journal_id_ASTM / _citation.journal_id_CSD / _citation.journal_id_ISSN / _citation.journal_volume / _citation.pdbx_database_id_DOI / _citation.pdbx_database_id_PubMed / _citation.title / _citation.year
Revision 1.2Oct 18, 2023Group: Data collection / Refinement description
Category: chem_comp_atom / chem_comp_bond / pdbx_initial_refinement_model
Revision 1.3Oct 30, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature / Item: _pdbx_entry_details.has_protein_modification

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Tumor necrosis factor ligand superfamily member 14, membrane form
B: Tumor necrosis factor ligand superfamily member 14, membrane form
C: Tumor necrosis factor ligand superfamily member 14, membrane form
D: CD160 antigen, soluble form,Tumor necrosis factor receptor superfamily member 14
E: CD160 antigen, soluble form,Tumor necrosis factor receptor superfamily member 14
F: CD160 antigen, soluble form,Tumor necrosis factor receptor superfamily member 14
hetero molecules


Theoretical massNumber of molelcules
Total (without water)136,54312
Polymers133,5106
Non-polymers3,0336
Water00
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area15530 Å2
ΔGint-10 kcal/mol
Surface area48260 Å2
MethodPISA
Unit cell
Length a, b, c (Å)214.689, 214.689, 214.689
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number197
Space group name H-MI23

-
Components

#1: Protein Tumor necrosis factor ligand superfamily member 14, membrane form


Mass: 18188.549 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: TNFSF14, HVEML, LIGHT, UNQ391/PRO726 / Plasmid: pCoBlast / Production host: Drosophila melanogaster (fruit fly) / Strain (production host): S2 / References: UniProt: O43557
#2: Protein CD160 antigen, soluble form,Tumor necrosis factor receptor superfamily member 14 / Herpes virus entry mediator A / Tumor necrosis factor receptor-like 2


Mass: 26314.684 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Details: single chain hCD160-hHVEM fusion protein / Source: (gene. exp.) Homo sapiens (human) / Gene: CD160, BY55, TNFRSF14, HVEA, HVEM, UNQ329/PRO509 / Plasmid: pMT/Bip/V5-His / Production host: Drosophila melanogaster (fruit fly) / Strain (production host): S2 / References: UniProt: O95971, UniProt: Q92956
#3: Polysaccharide 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose


Type: oligosaccharide / Mass: 424.401 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
DescriptorTypeProgram
DGlcpNAcb1-4DGlcpNAcb1-ROHGlycam Condensed SequenceGMML 1.0
WURCS=2.0/1,2,1/[a2122h-1b_1-5_2*NCC/3=O]/1-1/a4-b1WURCSPDB2Glycan 1.1.0
[][D-1-deoxy-GlcpNAc]{[(4+1)][b-D-GlcpNAc]{}}LINUCSPDB-CARE
#4: Polysaccharide beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta- ...beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose


Type: oligosaccharide / Mass: 586.542 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
DescriptorTypeProgram
DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ROHGlycam Condensed SequenceGMML 1.0
WURCS=2.0/2,3,2/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5]/1-1-2/a4-b1_b4-c1WURCSPDB2Glycan 1.1.0
[][D-1-deoxy-GlcpNAc]{[(4+1)][b-D-GlcpNAc]{[(4+1)][b-D-Manp]{}}}LINUCSPDB-CARE
Has ligand of interestN
Has protein modificationY
Sequence detailsChains D, E, and F each consist of a single chain hCD160-hHVEM fusion protein: UNP O95971 (CD160 ...Chains D, E, and F each consist of a single chain hCD160-hHVEM fusion protein: UNP O95971 (CD160 amino acids 27-144) - (G4S)4 LINKER - UNP Q92956 (TNFRSF14 amino acids 39-143) - GHHHHHH

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 3.09 Å3/Da / Density % sol: 60.17 %
Crystal growTemperature: 291 K / Method: vapor diffusion / pH: 7 / Details: 0.2 M potassium iodide, 20% PEG 3350

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 31-ID / Wavelength: 0.97931 Å
DetectorType: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Jul 21, 2016
RadiationMonochromator: diamond / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97931 Å / Relative weight: 1
ReflectionResolution: 3.5→34.83 Å / Num. obs: 20868 / % possible obs: 99.9 % / Redundancy: 20.7 % / CC1/2: 0.999 / Rmerge(I) obs: 0.195 / Rpim(I) all: 0.044 / Rrim(I) all: 0.2 / Net I/σ(I): 16.1
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. measured allNum. unique obsCC1/2Rpim(I) allRrim(I) allNet I/σ(I) obs% possible all
3.5-3.8317.91.7188839049360.6760.4141.7672.2100
8.57-34.8320.90.03430804147410.0080.03573.898.5

-
Processing

Software
NameVersionClassification
REFMAC5.8.0258refinement
XDSdata reduction
SCALEPACKdata scaling
MOLREPphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 4RSU, 6NG9

4rsu

6ng9


Resolution: 3.5→19.933 Å / Cor.coef. Fo:Fc: 0.919 / Cor.coef. Fo:Fc free: 0.894 / SU B: 38.58 / SU ML: 0.568 / Cross valid method: THROUGHOUT / ESU R Free: 0.651
Details: Hydrogens have been added in their riding positions. NCS restraints were applied during refinement: chains ABC were restrained tightly together (positional 0.05A, thermal 0.50A^2), and ...Details: Hydrogens have been added in their riding positions. NCS restraints were applied during refinement: chains ABC were restrained tightly together (positional 0.05A, thermal 0.50A^2), and chains DEF were restrained tightly together (positional 0.05A, thermal 0.50A^2).
RfactorNum. reflection% reflection
Rfree0.2847 1001 4.821 %
Rwork0.2566 19764 -
all0.258 --
obs-20765 99.33 %
Solvent computationIon probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK BULK SOLVENT
Displacement parametersBiso mean: 139.931 Å2
Baniso -1Baniso -2Baniso -3
1-0 Å20 Å20 Å2
2--0 Å20 Å2
3---0 Å2
Refinement stepCycle: LAST / Resolution: 3.5→19.933 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms7929 0 201 0 8130
Refine LS restraints
Refine-IDTypeDev idealDev ideal targetNumber
X-RAY DIFFRACTIONr_bond_refined_d0.0050.0138334
X-RAY DIFFRACTIONr_bond_other_d0.0120.0177536
X-RAY DIFFRACTIONr_angle_refined_deg1.291.68211307
X-RAY DIFFRACTIONr_angle_other_deg1.521.60417547
X-RAY DIFFRACTIONr_dihedral_angle_1_deg7.18751023
X-RAY DIFFRACTIONr_dihedral_angle_2_deg30.31520.923390
X-RAY DIFFRACTIONr_dihedral_angle_3_deg16.113151326
X-RAY DIFFRACTIONr_dihedral_angle_4_deg14.9921560
X-RAY DIFFRACTIONr_chiral_restr0.0470.21107
X-RAY DIFFRACTIONr_gen_planes_refined0.0040.029174
X-RAY DIFFRACTIONr_gen_planes_other0.0060.021752
X-RAY DIFFRACTIONr_nbd_refined0.1610.21305
X-RAY DIFFRACTIONr_symmetry_nbd_other0.1930.26946
X-RAY DIFFRACTIONr_nbtor_refined0.1530.23712
X-RAY DIFFRACTIONr_symmetry_nbtor_other0.0910.23823
X-RAY DIFFRACTIONr_xyhbond_nbd_refined0.1340.2182
X-RAY DIFFRACTIONr_symmetry_xyhbond_nbd_other0.0920.25
X-RAY DIFFRACTIONr_symmetry_nbd_refined0.3860.217
X-RAY DIFFRACTIONr_nbd_other0.3490.235
X-RAY DIFFRACTIONr_symmetry_xyhbond_nbd_refined0.1950.22
X-RAY DIFFRACTIONr_mcbond_it4.08214.9414155
X-RAY DIFFRACTIONr_mcbond_other4.07914.9414154
X-RAY DIFFRACTIONr_mcangle_it7.1422.3735157
X-RAY DIFFRACTIONr_mcangle_other7.1422.3745158
X-RAY DIFFRACTIONr_scbond_it3.21515.5714178
X-RAY DIFFRACTIONr_scbond_other3.21415.5714178
X-RAY DIFFRACTIONr_scangle_it5.84323.2376149
X-RAY DIFFRACTIONr_scangle_other5.84323.246150
X-RAY DIFFRACTIONr_lrange_it13.761281.46531096
X-RAY DIFFRACTIONr_lrange_other13.762281.42431091
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.5-3.5870.293540.371434X-RAY DIFFRACTION99.9328
3.587-3.6820.355560.3531366X-RAY DIFFRACTION100
3.682-3.7850.353590.3241374X-RAY DIFFRACTION100
3.785-3.8970.328560.3071300X-RAY DIFFRACTION100
3.897-4.020.304630.2921271X-RAY DIFFRACTION100
4.02-4.1550.271790.2991215X-RAY DIFFRACTION99.9228
4.155-4.3050.358660.2711171X-RAY DIFFRACTION99.9192
4.305-4.4720.337810.2351153X-RAY DIFFRACTION99.919
4.472-4.660.207610.2091086X-RAY DIFFRACTION99.9129
4.66-4.8740.255620.221059X-RAY DIFFRACTION99.9109
4.874-5.1210.244400.2221021X-RAY DIFFRACTION100
5.121-5.4090.325300.238967X-RAY DIFFRACTION100
5.409-5.7530.288530.247920X-RAY DIFFRACTION100
5.753-6.1710.278440.254842X-RAY DIFFRACTION100
6.171-6.6960.337350.293809X-RAY DIFFRACTION100
6.696-7.3830.359440.27731X-RAY DIFFRACTION100
7.383-8.3370.241350.227645X-RAY DIFFRACTION100
8.337-9.7910.238420.22574X-RAY DIFFRACTION100
9.791-12.4280.261200.211477X-RAY DIFFRACTION100
12.428-19.9330.246210.264361X-RAY DIFFRACTION99.7389

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more